The Latest Cardiac and Vascular News
Firm exceeds $300 million target with Fund V; expands its base of limited partners; announces promotions of Dennis McWilliams and Omar Khalil to Managing Directors AUSTIN, Texas, Feb. 2, 2026 /PRNewswire/ — Santé Ventures, a leading early-stage healthcare and life sciences investment firm, today announced the close of its fifth fund with $330 […]
MENLO PARK, Calif., April 5, 2022 /PRNewswire/ — Endovascular Engineering (“E2”), a privately-held developer of next-generation thrombectomy devices to treat patients with Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE), today announced the closing of a $15 million Series A1 financing. The financing was co-led by Santé Ventures and Cordis, who were joined by […]
This week on Investor Insights, host Ken Dropiewski interviews James Eadie, Managing Director of Santé Ventures. They discuss a number of topics including James’s journey into Santé Ventures, Santé’s portfolio, and the working relationship between Santé and early stage companies.
AUSTIN, Texas, Jan. 5, 2021 /PRNewswire/ — Santé Ventures (Santé), an early-stage healthcare and life sciences investment firm, today announced a series of end-of-year senior appointments and promotions, including naming two new Partners, to strengthen the firm’s senior leadership team across venture investing, capital formation, and data & analytics. James Eadie, MD, a current […]
